Marilda Aparecida Milanez Morgado de Abreu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marilda Aparecida Milanez Morgado de Abreu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Joel Carlos Lastória
Universidade Estadual Paulista "Júlio de Mesquita Filho" (Unesp) - Botucatu (SP), Brazil
3 shared publicationsCleonice Hitomi Watashi Hirata
Federal University of São Paulo
2 shared publicationsLuc Louis Maurice Weckx
2 shared publicationsA. M. Roselino
Ribeirão Preto College of Medicine, University of São Paulo Multiuser Molecular Biology Laboratory, Division of Dermatology, Department of Clinical Medicine Ribeirão Preto SP Brazil
1 shared publicationDalva Regina Neto Pimentel
1 shared publicationL. E. Prestes‐Carneiro
Presidente Prudente Regional Hospital, University of Oeste Paulista Dermatology Unit Presidente Prudente SP Brazil
1 shared publication
Latest Publications
- Open Access
- 1 June 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (3) , 393-395
Brazilian Society of Dermatology against leprosy
The Brazilian Society of Dermatology promoted a national campaign against leprosy in 2012, involving their State Regional, Accredited Services of Dermatology and Referral Services in Leprosy. Consisted of clarification to the population about the disease and a day of medical voluntary service. Ninety services (57 Accredited Services and 33 Reference Services) participated, distributed in 23 states. The campaign examined 3,223 people and 421 new cases were diagnosed, 54,4% female, 74,3% between 19 and 64 years and 8,3% in children under 15 years. Of the 217 classified cases, 58,5% was paucibacillary and 41,5% was multibacillary. The results were posted on the Brazilian Society of Dermatology website.
- 1 June 2016
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 91 (3) , 393-395
Open AccessBrazilian Society of Dermatology against leprosy
The Brazilian Society of Dermatology promoted a national campaign against leprosy in 2012, involving their State Regional, Accredited Services of Dermatology and Referral Services in Leprosy. Consisted of clarification to the population about the disease and a day of medical voluntary service. Ninety services (57 Accredited Services and 33 Reference Services) participated, distributed in 23 states. The campaign examined 3,223 people and 421 new cases were diagnosed, 54,4% female, 74,3% between 19 and 64 years and 8,3% in children under 15 years. Of the 217 classified cases, 58,5% was paucibacillary and 41,5% was multibacillary. The results were posted on the Brazilian Society of Dermatology website.
- Open Access
- 1 June 2014
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 89 (3) , 389-401
Leprosy: a review of laboratory and therapeutic aspects - Part 2
Leprosy is a chronic infectious condition caused by Mycobacterium leprae(M. leprae). It is endemic in many regions of the world and a public health problem in Brazil. Additionally, it presents a wide spectrum of clinical manifestations, which are dependent on the interaction between M. leprae and host, and are related to the degree of immunity to the bacillus. The diagnosis of this disease is a clinical one. However, in some situations laboratory exams are necessary to confirm the diagnosis of leprosy or classify its clinical form. This article aims to update dermatologists on leprosy, through a review of complementary laboratory techniques that can be employed for the diagnosis of leprosy, including Mitsuda intradermal reaction, skin smear microscopy, histopathology, serology, immunohistochemistry, polymerase chain reaction, imaging tests, electromyography, and blood tests. It also aims to explain standard multidrug therapy regimens, the treatment of reactions and resistant cases, immunotherapy with bacillus Calmette-Guérin (BCG) vaccine and chemoprophylaxis.
- 1 June 2014
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 89 (3) , 389-401
Open AccessLeprosy: a review of laboratory and therapeutic aspects - Part 2
Leprosy is a chronic infectious condition caused by Mycobacterium leprae(M. leprae). It is endemic in many regions of the world and a public health problem in Brazil. Additionally, it presents a wide spectrum of clinical manifestations, which are dependent on the interaction between M. leprae and host, and are related to the degree of immunity to the bacillus. The diagnosis of this disease is a clinical one. However, in some situations laboratory exams are necessary to confirm the diagnosis of leprosy or classify its clinical form. This article aims to update dermatologists on leprosy, through a review of complementary laboratory techniques that can be employed for the diagnosis of leprosy, including Mitsuda intradermal reaction, skin smear microscopy, histopathology, serology, immunohistochemistry, polymerase chain reaction, imaging tests, electromyography, and blood tests. It also aims to explain standard multidrug therapy regimens, the treatment of reactions and resistant cases, immunotherapy with bacillus Calmette-Guérin (BCG) vaccine and chemoprophylaxis.
- Top Cited PapersOpen Access
- 1 April 2014
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 89 (2) , 205-218
Leprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1
Leprosy is caused by Mycobacterium leprae and has been known since biblical times. It is still endemic in many regions of the world and a public health problem in Brazil. The prevalence rate in 2011 reached 1.54 cases per 10,000 inhabitants in Brazil. The mechanism of transmission of leprosy consists of prolonged close contact between susceptible and genetically predisposed individuals and untreated multibacillary patients. Transmission occurs through inhalation of bacilli present in upper airway secretion. The nasal mucosa is the main entry or exit route of M. leprae. The deeper understanding of the structural and biological characteristics of M. leprae, the sequencing of its genome, along with the advances in understanding the mechanisms of host immune response against the bacilli, dependent on genetic susceptibility, have contributed to the understanding of the pathogenesis, variations in the clinical characteristics, and progression of the disease. This article aims to update dermatologist on epidemiological, clinical, and etiopathogenic leprosy aspects.
- 1 April 2014
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 89 (2) , 205-218
Top Cited PapersOpen AccessLeprosy: review of the epidemiological, clinical, and etiopathogenic aspects - Part 1
Leprosy is caused by Mycobacterium leprae and has been known since biblical times. It is still endemic in many regions of the world and a public health problem in Brazil. The prevalence rate in 2011 reached 1.54 cases per 10,000 inhabitants in Brazil. The mechanism of transmission of leprosy consists of prolonged close contact between susceptible and genetically predisposed individuals and untreated multibacillary patients. Transmission occurs through inhalation of bacilli present in upper airway secretion. The nasal mucosa is the main entry or exit route of M. leprae. The deeper understanding of the structural and biological characteristics of M. leprae, the sequencing of its genome, along with the advances in understanding the mechanisms of host immune response against the bacilli, dependent on genetic susceptibility, have contributed to the understanding of the pathogenesis, variations in the clinical characteristics, and progression of the disease. This article aims to update dermatologist on epidemiological, clinical, and etiopathogenic leprosy aspects.
- Open Access
- 1 January 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (1) , 59-64
Mycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients
- 1 January 2014
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 20 (1) , 59-64
Open AccessMycobacterium leprae is identified in the oral mucosa from paucibacillary and multibacillary leprosy patients
- Open Access
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Otorhinolaryngology
- Vol. 78 (4) , 8
Papilas filiformes não têm botões gustativos: resposta
- 1 August 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Otorhinolaryngology
- Vol. 78 (4) , 8
Open AccessPapilas filiformes não têm botões gustativos: resposta
- 1 November 2009
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 108 (5) , 714-721
Treatment of recurrent aphthous stomatitis with clofazimine
- 1 November 2009
- Published by Elsevier in Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
- Vol. 108 (5) , 714-721
Treatment of recurrent aphthous stomatitis with clofazimine